Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma
Anne Lok,
Julie Mocquard,
Jessie Bourcier,
Laurence Redelsperger,
Antoine Bonnet,
Cecile Chauvin,
Patrick Thomaré,
Beatrice Mahé,
Cyrille Touzeau,
Philippe Moreau
Affiliations
Anne Lok
Hematology Department, University Hospital, Nantes, France
Julie Mocquard
Hematology Department, University Hospital, Nantes, France
Jessie Bourcier
Hematology Department, University Hospital, Nantes, France
Laurence Redelsperger
Hematology Department, University Hospital, Nantes, France
Antoine Bonnet
Hematology Department, University Hospital, Nantes, France
Cecile Chauvin
Hematology Department, University Hospital, Nantes, France
Patrick Thomaré
Hematology Department, University Hospital, Nantes, France
Beatrice Mahé
Hematology Department, University Hospital, Nantes, France
Cyrille Touzeau
Hematology Department, University Hospital, Nantes, France
Philippe Moreau
Hematology Department, University Hospital, Nantes, France
